Trial Profile
A Phase I Dose Escalating Study Evaluating the Pharmacokinetics, Tolerability and Safety of Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Istaroxime (Primary)
- Indications Decompensated heart failure
- Focus Adverse reactions
- Sponsors Lee's Pharmaceutical
- 25 Jun 2015 New trial record